| Mark C Ballard, MD | |
|
901 Montgomery St, Decorah, IA 52101-2325 | |
| (563) 382-2911 | |
| (563) 382-1507 |
| Full Name | Mark C Ballard |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 901 Montgomery St, Decorah, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801909718 | NPI | - | NPPES |
| 117665000 | Medicaid | WY | |
| 0008113 | Other | SD | BC/BS PROVIDER # |
| 6200920 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD52141 (Iowa) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 4683 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Winneshiek Medical Center | Decorah, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rural Health Care Inc | 3476447541 | 130 |
News Archive
MedClean Technologies, Inc., the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced financial results for the 2010 second quarter for the period ended June 30, 2010.
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.
An incision about half the length used for traditional surgery works just as well in removing diseased thyroids, researchers have found.
› Verified 7 days ago
| Entity Name | Sanford Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790721280 PECOS PAC ID: 6800707100 Enrollment ID: O20031111000266 |
News Archive
MedClean Technologies, Inc., the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced financial results for the 2010 second quarter for the period ended June 30, 2010.
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.
An incision about half the length used for traditional surgery works just as well in removing diseased thyroids, researchers have found.
› Verified 7 days ago
| Entity Name | Avera Queen Of Peace |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205359031 PECOS PAC ID: 9335050806 Enrollment ID: O20031229000301 |
News Archive
MedClean Technologies, Inc., the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced financial results for the 2010 second quarter for the period ended June 30, 2010.
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.
An incision about half the length used for traditional surgery works just as well in removing diseased thyroids, researchers have found.
› Verified 7 days ago
| Entity Name | Rural Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720076441 PECOS PAC ID: 3476447541 Enrollment ID: O20040210000648 |
News Archive
MedClean Technologies, Inc., the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced financial results for the 2010 second quarter for the period ended June 30, 2010.
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.
An incision about half the length used for traditional surgery works just as well in removing diseased thyroids, researchers have found.
› Verified 7 days ago
| Entity Name | Sanford Health Network |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1134140825 PECOS PAC ID: 6800707100 Enrollment ID: O20061104000503 |
News Archive
MedClean Technologies, Inc., the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced financial results for the 2010 second quarter for the period ended June 30, 2010.
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.
An incision about half the length used for traditional surgery works just as well in removing diseased thyroids, researchers have found.
› Verified 7 days ago
| Entity Name | Ballard Gynecology Prof Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336589936 PECOS PAC ID: 0840434239 Enrollment ID: O20130925000677 |
News Archive
MedClean Technologies, Inc., the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced financial results for the 2010 second quarter for the period ended June 30, 2010.
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.
An incision about half the length used for traditional surgery works just as well in removing diseased thyroids, researchers have found.
› Verified 7 days ago
| Entity Name | Avera Queen Of Peace |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1992466635 PECOS PAC ID: 9335050806 Enrollment ID: O20220301001771 |
News Archive
MedClean Technologies, Inc., the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced financial results for the 2010 second quarter for the period ended June 30, 2010.
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.
An incision about half the length used for traditional surgery works just as well in removing diseased thyroids, researchers have found.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark C Ballard, MD 901 Montgomery St, Decorah, IA 52101-2325 Ph: (563) 382-2911 | Mark C Ballard, MD 901 Montgomery St, Decorah, IA 52101-2325 Ph: (563) 382-2911 |
News Archive
MedClean Technologies, Inc., the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced financial results for the 2010 second quarter for the period ended June 30, 2010.
Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.
Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.
An incision about half the length used for traditional surgery works just as well in removing diseased thyroids, researchers have found.
› Verified 7 days ago
Dr. Randall J Bremner, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 Fax: 563-387-3102 |